Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.

Bowton E, Saunders C, Erreger K, Sakrikar D, Matthies HJ, Sen N, Jessen T, Colbran RJ, Caron MG, Javitch JA, Blakely RD, Galli A.

J Neurosci. 2010 Apr 28;30(17):6048-57. doi: 10.1523/JNEUROSCI.5094-09.2010.

PMID:
20427663
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Anomalous dopamine release associated with a human dopamine transporter coding variant.

Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, Blakely RD.

J Neurosci. 2008 Jul 9;28(28):7040-6. doi: 10.1523/JNEUROSCI.0473-08.2008.

PMID:
18614672
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.

Sakrikar D, Mazei-Robison MS, Mergy MA, Richtand NW, Han Q, Hamilton PJ, Bowton E, Galli A, Veenstra-Vanderweele J, Gill M, Blakely RD.

J Neurosci. 2012 Apr 18;32(16):5385-97. doi: 10.1523/JNEUROSCI.6033-11.2012. Erratum in: J Neurosci. 2012 Oct 31;32(44):15643.

PMID:
22514303
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.

Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, Fog JU, Zhang M, Sen N, Colbran RJ, Gnegy ME, Gether U, Javitch JA, Erreger K, Galli A.

Mol Pharmacol. 2008 Oct;74(4):1101-8. doi: 10.1124/mol.108.048447. Epub 2008 Jul 10.

PMID:
18617632
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism.

Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS.

Mol Pharmacol. 2007 May;71(5):1222-32. Epub 2007 Jan 31.

PMID:
17267664
[PubMed - indexed for MEDLINE]
Free Article
6.

SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.

Bowton E, Saunders C, Reddy IA, Campbell NG, Hamilton PJ, Henry LK, Coon H, Sakrikar D, Veenstra-VanderWeele JM, Blakely RD, Sutcliffe J, Matthies HJ, Erreger K, Galli A.

Transl Psychiatry. 2014 Oct 14;4:e464. doi: 10.1038/tp.2014.90.

PMID:
25313507
[PubMed - in process]
7.

ADHD and the dopamine transporter: are there reasons to pay attention?

Mazei-Robinson MS, Blakely RD.

Handb Exp Pharmacol. 2006;(175):373-415. Review.

PMID:
16722244
[PubMed - indexed for MEDLINE]
8.

Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine.

Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S, Martella G, Nisticò R, Centonze D, Pisani A, Gu HH, Mercuri NB, Usiello A.

J Neurosci. 2010 Aug 18;30(33):11043-56. doi: 10.1523/JNEUROSCI.1682-10.2010.

PMID:
20720111
[PubMed - indexed for MEDLINE]
Free Article
9.

Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome.

Steinkellner T, Yang JW, Montgomery TR, Chen WQ, Winkler MT, Sucic S, Lubec G, Freissmuth M, Elgersma Y, Sitte HH, Kudlacek O.

J Biol Chem. 2012 Aug 24;287(35):29627-35. doi: 10.1074/jbc.M112.367219. Epub 2012 Jul 9.

PMID:
22778257
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.

Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD.

Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):E4779-88. doi: 10.1073/pnas.1417294111. Epub 2014 Oct 20.

PMID:
25331903
[PubMed - in process]
11.

Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum.

Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gerhardt GA, Zahniser NR.

J Neurochem. 1999 Jan;72(1):148-56.

PMID:
9886065
[PubMed - indexed for MEDLINE]
12.

Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate.

Xu TX, Sotnikova TD, Liang C, Zhang J, Jung JU, Spealman RD, Gainetdinov RR, Yao WD.

J Neurosci. 2009 Nov 11;29(45):14086-99. doi: 10.1523/JNEUROSCI.0974-09.2009.

PMID:
19906957
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.

Patel J, Mooslehner KA, Chan PM, Emson PC, Stamford JA.

J Neurochem. 2003 May;85(4):898-910.

PMID:
12716422
[PubMed - indexed for MEDLINE]
14.

Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice.

Wu N, Cepeda C, Zhuang X, Levine MS.

J Neurophysiol. 2007 Jul;98(1):423-32. Epub 2007 May 23.

PMID:
17522168
[PubMed - indexed for MEDLINE]
Free Article
15.

Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder.

Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD.

Neuropharmacology. 2005 Nov;49(6):724-36. Epub 2005 Sep 19.

PMID:
16171832
[PubMed - indexed for MEDLINE]
16.

Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.

Pristupa ZB, McConkey F, Liu F, Man HY, Lee FJ, Wang YT, Niznik HB.

Synapse. 1998 Sep;30(1):79-87.

PMID:
9704884
[PubMed - indexed for MEDLINE]
17.

Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.

Schmitz Y, Lee CJ, Schmauss C, Gonon F, Sulzer D.

J Neurosci. 2001 Aug 15;21(16):5916-24.

PMID:
11487614
[PubMed - indexed for MEDLINE]
Free Article
18.

Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.

Hansen FH, Skjørringe T, Yasmeen S, Arends NV, Sahai MA, Erreger K, Andreassen TF, Holy M, Hamilton PJ, Neergheen V, Karlsborg M, Newman AH, Pope S, Heales SJ, Friberg L, Law I, Pinborg LH, Sitte HH, Loland C, Shi L, Weinstein H, Galli A, Hjermind LE, Møller LB, Gether U.

J Clin Invest. 2014 Jul 1;124(7):3107-20. doi: 10.1172/JCI73778. Epub 2014 Jun 9.

PMID:
24911152
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport.

Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, Daws LC, Sitte HH, Javitch JA, Galli A, Gether U.

Neuron. 2006 Aug 17;51(4):417-29.

PMID:
16908408
[PubMed - indexed for MEDLINE]
Free Article
20.

Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter.

Castelli M, Federici M, Rossi S, De Chiara V, Napolitano F, Studer V, Motta C, Sacchetti L, Romano R, Musella A, Bernardi G, Siracusano A, Gu HH, Mercuri NB, Usiello A, Centonze D.

Eur J Neurosci. 2011 Nov;34(9):1369-77. doi: 10.1111/j.1460-9568.2011.07876.x.

PMID:
22034972
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk